TAG:
diagnostic market
Optimism & Opportunity at Executive War College
By Robert Michel | From the Volume XVII No. 7 – May 10, 2010 Issue
CEO SUMMARY: Instead of our annual review of key speakers as a source of emerging trends and common themes, this year we assess the attitudes, opinions, and activities of the pathologists, laboratory administrators, managers, and industry executives in attendance at the 15th Annu…
2006’s Top Lab Stories Identify New Threats
By Robert Michel | From the Volume XIII No. 17 – December 18, 2006 Issue
CEO SUMMARY: Presented here are THE DARK REPORT’S “Ten Biggest Lab Stories of 2006.” Compared to earlier years, 2006 was not transformative for the laboratory industry. But it was an eventful year, particularly influenced by Siemens’ decision to acquire DPC and Bayer Diagnostics, …
Bio-Rad Buys Ciphergen’s Proteomics Technology
By Robert Michel | From the Volume XIII No. 12 – September 5, 2006 Issue
PROTEOMICS IS EXPECTED TO BE ONE of the most active areas in molecular diagnostics and Bio-Rad Laboratories, Inc. has just staked a major claim to a promising proteomic technology. In a transaction announced on August 18, 2006, Bio-Rad will acquire the proprietary proteomics instrum…
May 1, 2006 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XIII No. 6 – May 1, 2006 Issue
Lots of news unfolding across the lab industry. Here’s a round-up of recent and noteworthy items: NEW VENTURES • Persistent rumors indicate that a new national ana…
Oncology’s Potential Drives AP Lab Expansion
By Robert Michel | From the Volume XI No. 12 – August 30, 2004 Issue
CEO SUMMARY: It is no coincidence that another public company is shifting its business focus and expanding its efforts to capture cancer-related anatomic pathology specimens. Demographic trends predict a steady increase in the number of new cancer cases yearly, while new technologies are …
Looking at Fast-Growth And Slow-Growth Areas In Diagnostic Testing
By Robert Michel | From the Volume X No. 14 – October 20, 2003 Issue
CEO SUMMARY: This exclusive intelligence briefing predicts how specific new technologies may drive changes in the laboratory-testing marketplace during the next five years. The key message is that change is expected to be incremental, not disruptive—given the technology known to be in d…
Dynacare, LabCorp, IMPATH, Visible Genetics, Abbott Labs
By Robert Michel | From the Volume IX No. 6 – April 22, 2002 Issue
ACTIVITY AT DYNACARE HINTS AT POSSIBLE SALE, LABCORP MAY BE BUYER With Quest Diagnostics Incorporated snapping up independent lab companies right and left in recent months, the question asked by many is “Where’s Laboratory Corporation of America?” On …
Bill Bonello Sees Opportunities In Diagnostic Services Companies
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
CEO SUMMARY: With the clinical laboratory industry now enjoying growing interest by professional investors, THE DARK REPORT traveled to New York City to meet with financial analyst William B. Bonello, of U S Bancorp Piper Jaffray. Bonello co-authored a just-released overview of what he ca…
Court Rules Against Roche In PCR/Taq Patent Dispute
By Robert Michel | From the Volume VI No. 17 – December 13, 1999 Issue
DECEMBER 7, 1999 WAS NOT an auspicious day for Hoffmann-LaRoche. One of its patents related to the PCR testing process was ruled invalid by a Federal District Court. The ruling involved Roche’s ’818 Taq patent, an enzyme used in the PCR process. The Court found that the patent h…
How Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized